Five companies—Coca-Cola, Colgate-Palmolive, AT&T, Dominion Energy, and Pfizer—offer dividend stocks that provide steady income with less market volatility, ideal for investors seeking stability. These companies sell essential products or services that maintain demand during economic downturns, supporting reliable dividends. Yields range from about 2.3% for consumer staples to nearly 6% for Pfizer, with dividend safety supported by strong cash flow and earnings. Investors should watch upcoming dividend dates, debt management, and merger approvals for these stocks.
Pfizer stands out with a dividend yield of 5.81% and a market cap of $168.60 billion, highlighting its role as a high-yield income stock. On Pluang, Pfizer trades at USD 29.44 with a slight 0.47% decrease as of Oct 20, 2026 01:02 WIB. Coca-Cola, with a much larger market cap of $404.01 billion and a dividend yield of 2.26%, shows steadier investor interest, reflected in its 37% buy activity on Pluang.
Five well-known dividend stocks—Kraft Heinz, Pfizer, Dow Inc., Verizon, and AT&T—are showing warning signs that their high dividend yields may not be sustainable. Issues include earnings and cash flow shortfalls, rising debt, and dividend payouts exc...
Novavax stock dropped 12% due to heavy selling pressure on vaccine makers, with Moderna also falling 10% while Pfizer remained stable. Novavax depends on Sanofi to commercialize its COVID vaccine, making its revenue reliant on Sanofi's rollout and mi...
Moderna's stock dropped 10% following a strong rally driven by its personalized cancer vaccine progress. The decline is seen as profit taking ahead of a critical late-stage melanoma trial data release expected later this month. Moderna's oncology eff...
Moderna shares surged 6% amid a broader market rotation from AI and tech stocks into healthcare, outperforming peers BioNTech and Pfizer. This rally is supported by positive clinical data from August showing Moderna's personalized mRNA cancer vaccine...
